KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Other Operating Expenses: 2017-2025

Historic Other Operating Expenses for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $48.8 million.

  • Twist Bioscience's Other Operating Expenses rose 3.65% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.7 million, marking a year-over-year decrease of 15.54%. This contributed to the annual value of $48.8 million for FY2025, which is 78.25% down from last year.
  • As of FY2025, Twist Bioscience's Other Operating Expenses stood at $48.8 million, which was down 78.25% from $224.6 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Other Operating Expenses registered a high of $224.6 million during FY2024, and its lowest value of $534,000 during FY2021.
  • In the last 3 years, Twist Bioscience's Other Operating Expenses had a median value of $48.8 million in 2025 and averaged $93.1 million.
  • In the last 5 years, Twist Bioscience's Other Operating Expenses tumbled by 99.13% in 2021 and then soared by 3,697.65% in 2024.
  • Yearly analysis of 5 years shows Twist Bioscience's Other Operating Expenses stood at $534,000 in 2021, then surged by 2,567.60% to $14.2 million in 2022, then slumped by 58.49% to $5.9 million in 2023, then skyrocketed by 3,697.65% to $224.6 million in 2024, then slumped by 78.25% to $48.8 million in 2025.